Correlation Between Nevro Corp and P3 Health
Can any of the company-specific risk be diversified away by investing in both Nevro Corp and P3 Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nevro Corp and P3 Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nevro Corp and P3 Health Partners, you can compare the effects of market volatilities on Nevro Corp and P3 Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nevro Corp with a short position of P3 Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nevro Corp and P3 Health.
Diversification Opportunities for Nevro Corp and P3 Health
0.45 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Nevro and PIIIW is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Nevro Corp and P3 Health Partners in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on P3 Health Partners and Nevro Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nevro Corp are associated (or correlated) with P3 Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of P3 Health Partners has no effect on the direction of Nevro Corp i.e., Nevro Corp and P3 Health go up and down completely randomly.
Pair Corralation between Nevro Corp and P3 Health
Given the investment horizon of 90 days Nevro Corp is expected to generate 0.46 times more return on investment than P3 Health. However, Nevro Corp is 2.17 times less risky than P3 Health. It trades about 0.15 of its potential returns per unit of risk. P3 Health Partners is currently generating about -0.41 per unit of risk. If you would invest 521.00 in Nevro Corp on December 1, 2024 and sell it today you would earn a total of 51.00 from holding Nevro Corp or generate 9.79% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 61.9% |
Values | Daily Returns |
Nevro Corp vs. P3 Health Partners
Performance |
Timeline |
Nevro Corp |
P3 Health Partners |
Nevro Corp and P3 Health Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Nevro Corp and P3 Health
The main advantage of trading using opposite Nevro Corp and P3 Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nevro Corp position performs unexpectedly, P3 Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in P3 Health will offset losses from the drop in P3 Health's long position.Nevro Corp vs. Integer Holdings Corp | Nevro Corp vs. Glaukos Corp | Nevro Corp vs. CONMED | Nevro Corp vs. Pulmonx Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Equity Valuation Check real value of public entities based on technical and fundamental data |